Skip to content
NewsBlazeAU – Lifestyle
Author:
NRG Therapeutics Limited
NRG Therapeutics Presents Data on Lead Clinical Asset NRG5051 Confirming Novel Disease-Modifying Approach to ALS
August 28, 2026
NRG Therapeutics Announces the Appointment of Claus Sundgreen M.D. as Chief Medical Officer
August 3, 2026